The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.375
Bid: 7.25
Ask: 7.50
Change: -0.25 (-3.28%)
Spread: 0.25 (3.448%)
Open: 7.625
High: 7.625
Low: 7.375
Prev. Close: 7.625
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Ixico revenue falls, Solid State boosts profit

Tue, 05th Dec 2023 14:31

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Ixico PLC - London-based precision analytics company working to advance investigational therapies for neurological diseases - Revenue for the year that ended on September 30 falls 23% to GBP6.7 million from GBP8.6 million the year before. Company swings to GBP1.4 million pretax loss following a GBP885,000 profit. Total operating expenses increase to GBP5.1 million from GBP5.0 million. Ixico says revenue drop was expected and caused by the now-realised impact of clients ceasing multiple large "failed" trials across 2021 and early 2022. Expects to deliver roughly flat revenue in the current financial year before returning to growth in 2025.

----------

Supply@Me Capital PLC - London-based fintech platform provider - Says it has so far received GBP1.4 million from The AvantGarde Group SpA as a result of contractual payments. An additional GBP1.5 million remains outstanding. Also says it has made significant progress in the formalisation of its first White-Label IM agreement with an Italian banking group with a transaction valued at up to EUR10 million. Company is also working to finalise a framework to issue security tokens up to USD100 million to be subscribed in tranches.

----------

Lindsell Train Investment Trust PLC - London-based, rail-focused investment trust - Net asset value at September 30 is GBP968.75 per share, down from GBP1,056.95 at March 31. NAV total return for the six months to September 30 is negative 3.6%, underperforming the MSCI World Index with positive 4.5%. Says performance was impacted by high interest rates and inflation, and believes it may have to reduce its dividend. Notes reduced investor risk appetites and increased market volatility.

----------

Marechale Capital PLC - London-based corporate finance adviser - Revenue for the half year that ended on October 31 increased 91% to GBP320,603 from GBP168,001. Cost of sales more than doubles to GBP226,790 from GBP95,981. Pretax loss narrows to GBP155,803 from GBP179,502. Marechale says market is still challenging, especially in the hospitality sector, but that it remains positive about the outlook for its investments.

----------

Anglesey Mining PLC - Base metals miner with operations in North Wales, Sweden and Canada - Says drilling of the NCZ001 hole in the Northern Copper Zone at its Parys Mountain project on the Isle of Anglesey commenced on October 27, and is expected to complete over the next week. Expects results in the first quarter of 2024. Says initial logging suggests sulphide mineralisation commencing at around 350 metres deep. Chief Executive Jo Battershill says initial core is "very encouraging" as "we are seeing a significant amount of quartz veins within the system..[which] contain encouraging amounts of chalcopyrite, sphalerite, and galena – the key minerals that host copper, zinc and lead."

----------

Psych Capital PLC - London-based psychedelic medicines media firm and investor - Oscillate PLC continues to own 46.0 million shares in Psych, representing 12.75% of its issued share capital, following Psych's acquisition of Short Wave Pharma Inc which completed in November. Oscillate says it will continue to assess the investment to ascertain an exit opportunity. Says it meanwhile remains "optimistic at the advances that the Short Wave acquisition represents in the innovative psychedelics space." Oscillate also says that trials are due to start in the first quarter of 2024.

----------

Solid State PLC - Redditch, England-based supplier & design-in manufacturer of computing, power, and communications products - Pretax profit for the six months to September 30 is GBP6.1 million, up 45% from GBP4.2 million the prior year. Revenue increases 48% to GBP88.1 million from GBP59.4 million. Company declares 7.0 pence per share interim dividend, up 8% from 6.5p the year before. Says it is confident in meeting expectations for full-year results thanks to "record billings" and a "stable six-month order book". Open order book at October 31 stood at GBP108.6 million, slightly down from GBP112.5 million at September 30, 2022.

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
21 Apr 2022 22:06

TRADING UPDATES: Warehouse REIT buys Bradwell Abbey; Ixico wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
21 Apr 2022 13:50

Ixico selected for Huntington's disease detection study

(Sharecast News) - Artificial intelligence (AI) neuroimaging company Ixico announced on Thursday that it has been selected by a new client to support a global prospective observational study, assessing participants for the early detection of Huntington's disease (HD).

Read more
8 Mar 2022 15:31

Ixico wins £0.8m contract with existing US client

(Sharecast News) - Medical analysis company Ixico has been selected by an existing United States biotechnology client, it announced on Tuesday, to provide PET and MRI neuroimaging services for an open-label phase 1 and 2 dose-finding study.

Read more
8 Mar 2022 12:33

TRADING UPDATES: Tasty sales rise; Synectics wins National Grid deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
14 Feb 2022 11:39

Ixico shares rise with launch of new brain segmentation platform

(Alliance News) - Shares in Ixico PLC on Monday rose after the company announced the launch of its new brain segmentation platform IXIQ Ai.

Read more
8 Feb 2022 15:17

Ixico wins contract from new European biopharmaceutical client

(Sharecast News) - Medical imaging analytics company Ixico has been selected to provide PET and MRI imaging services to an unnamed "leading European biopharmaceutical company" specialising in neurodegenerative conditions, it announced on Tuesday.

Read more
8 Feb 2022 11:46

AIM WINNERS & LOSERS: Joules up on upbeat outlook; Numis quarter slow

AIM WINNERS & LOSERS: Joules up on upbeat outlook; Numis quarter slow

Read more
8 Feb 2022 10:06

Ixico wins GBP1 million contract to provide medical imaging services

Ixico wins GBP1 million contract to provide medical imaging services

Read more
26 Jan 2022 16:02

Ixico extends commitment to Dementias Platform UK

(Sharecast News) - Data analytics company Ixico has extended its commitment to Dementias Platform UK (DPUK), it announced on Wednesday, as it entered its second phase.

Read more
20 Jan 2022 14:35

IN BRIEF: IXICO will see 2022 revenue drop after contract canceled

IN BRIEF: IXICO will see 2022 revenue drop after contract canceled

Read more
20 Jan 2022 10:58

AIM WINNERS & LOSERS: Parity and Brave Bison expect to beat forecasts

AIM WINNERS & LOSERS: Parity and Brave Bison expect to beat forecasts

Read more
13 Jan 2022 14:52

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
7 Dec 2021 15:41

Ixico sees "significant growth" despite notable headwinds; shares up

Ixico sees "significant growth" despite notable headwinds; shares up

Read more
30 Nov 2021 16:26

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Nov 2021 15:43

Ixico tapped for another phase-3 clinical trial

(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been selected by its largest pharmaceutical client to provide neuroimaging services for a new phase 3 clinical trial focussed on a demyelinating disorder, it announced on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.